Donald S. Fredrickson

Donald S. Fredrickson's AcademicInfluence.com Rankings

Biology

#1898

World Rank

#3073

Historical Rank

Biochemistry

#144

World Rank

#182

Historical Rank

biology Degrees

Donald S. Fredrickson

Philosophy

#1838

World Rank

#3260

Historical Rank

Logic

#331

World Rank

#661

Historical Rank

philosophy Degrees

Download Badge

Biology
Philosophy

Donald S. Fredrickson's Degrees

Masters Medicine Columbia University
PhD Biochemistry Columbia University

Why Is Donald S. Fredrickson Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Donald S. Fredrickson's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. (1972) (31316)
Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. (1967) (860)
Classification of hyperlipidaemias and hyperlipoproteinaemias. (1970) (807)
A specific apoprotein activator for lipoprotein lipase. (1970) (607)
Coronary Artery Disease in 116 Kindred with Familial Type II Hyperlipoproteinemia (1974) (487)
Transport of fatty acids. (1958) (464)
Selective measurement of two lipase activities in postheparin plasma from normal subjects and patients with hyperlipoproteinemia. (1974) (456)
Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. (1967) (428)
Editorial: A System for Phenotyping Hyperlipoproteinemia (1965) (418)
Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. (2009) (405)
Studies of the proteins in human plasma very low density lipoproteins. (1969) (385)
The metabolism of sphingomyelin. II. Evidence of an enzymatic deficiency in Niemann-Pick diseae. (1966) (363)
The metabolism of albumin-bound C14-labeled unesterified fatty acids in normal human subjects. (1958) (324)
Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. (1967) (308)
Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred. (1999) (278)
The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice (2001) (261)
LIPOLYTIC ACTIVITY OF POST-HEPARIN PLASMA IN HYPERGLYCERIDEMIA. (1963) (260)
The biochemical, clinical, and genetic features of type III hyperlipoproteinemia. (1975) (254)
Tangier Disease: Combined Clinical Staff Conference at the National Institutes of Health (1961) (238)
A comparison of heritable abnormal lipoprotein patterns as defined by two different techniques. (1968) (236)
Comparison of the triglyceride lipase of liver, adipose tissue, and postheparin plasma. (1972) (235)
Selective measurement of two different triglyceride lipase activities in rat postheparin plasma. (1973) (234)
Complete genomic sequence of the human ABCA1 gene: analysis of the human and mouse ATP-binding cassette A promoter. (2000) (221)
The metabolism of chylomicra. I. The removal of palmitic acid-1-C14 labeled chylomicra from dog plasma. (1956) (210)
β-Sitosterolemia and Xanthomatosis (1976) (205)
Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia). A study of its biochemical, genetic and clinical presentation in childhood. (1974) (196)
Dietary and drug treatment of primary hyperlipoproteinemia. (1972) (186)
Type III hyperlipoproteinemia: an analysis of two contemporary definitions. (1975) (174)
Further Observations on the Activation and Inhibition of Lipoprotein Lipase by Apolipoproteins (1973) (171)
The nature of pre beta (very low density) lipoproteins. (1966) (169)
Further characterization of apolipoproteins from the human plasma very low density lipoproteins. (1970) (163)
Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. (1967) (160)
HETEROGENEITY OF PLASMA HIGH DENSITY LIPOPROTEINS. (1965) (159)
Tangier disease (familial high density lipoprotein deficiency). Clinical and genetic features in two adults. (1965) (156)
Neonatal diagnosis of familial type-II hyperlipoproteinaemia. (1973) (151)
Immunoreactive Insulin, Glucose Tolerance, and Carbohydrate Inducibility in Types II, III, IV, and V Hyperlipoproteinemia (1969) (149)
THE INHERITANCE OF HIGH DENSITY LIPOPROTEIN DEFICIENCY (TANGIER DISEASE). (1964) (140)
A SYSTEM FOR PHENOTYPING HYPERLIPOPROTEINEMIA. (1965) (132)
Fractionation of the C-apoproteins from human plasma very low density lipoproteins. (1973) (130)
Glycolipids and other lipid constituents of normal human liver. (1970) (128)
Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin. (1998) (128)
The pathology of Tangier disease. A light and electron microscopic study. (1975) (126)
The role of unesterified fatty acid transport in chylomicron metabolism. (1958) (123)
Enzyme deficiency in cholesteryl ester storage idisease. (1972) (123)
On the protein defect in abetalipoproteinemia. (1971) (121)
Characterization, subcellular localization, and partial purification of a heparin-released triglyceride lipase from rat liver. (1973) (114)
Classification of Hyperlipidemias and Hyperlipoproteinemias (1972) (106)
Evidence for the identity of the major apoprotein in low density and very low density lipoproteins in normal subjects and patients with familial hyperlipoproteinemia. (1972) (106)
Diagnosis and management of hyperlipoproteinemia. (1968) (105)
Further separation of the apoproteins of the human plasma very low density lipoproteins. (1970) (103)
Cardiovascular pathology in hyperlipoproteinemia. Anatomic observations in 42 necropsy patients with normal or abnormal serum lipoprotein patterns. (1973) (103)
Cholestyramine in type II hyperlipoproteinemia. A double-blind trial. (1973) (99)
Thf complete amino acid sequence of C-I (apoLp-Ser), an apolipoprotein from human very low density lipoproteins. (1975) (98)
Studies on the protein defect in Tangier disease. Isolation and characterization of an abnormal high density lipoprotein. (1972) (89)
Advances in the diagnosis and treatment of adrenal insufficiency. (1951) (86)
Deficiency of sphingomyelin-cleaving enzyme activity in tissue cultures derived from patients with Niemann-Pick disease. (1969) (86)
An improved technique for assay of C14O2 in expired air using the liquid scintillation counter. (1958) (84)
Evidence for separate monoglyceride hydrolase and triglyceride lipase in post-heparin human plasma. (1969) (84)
An international classification of hyperlipidemias and hyperlipoproteinemias. (1971) (83)
Further characterization of the apolipoproteins of rat plasma lipoproteins. (1970) (80)
Isolation and Characterization of an Abnormal High Density Lipoprotein in Tangier Disease (1977) (78)
INHIBITORS OF CHOLESTEROL BIOSYNTHESIS AND THE PROBLEM OF HYPERCHOLESTEROLEMIA (1956) (78)
Acquired type I hyperlipoproteinemia with systemic lupus erythematosus, dysglobulinemia and heparin resistance. (1969) (76)
On the lipoprotein abnormality in type III hyperlipoproteinemia (1971) (75)
Gaucher's Disease of the Lung Causing Severe Pulmonary Hypertension with Associated Acute Recurrent Pericarditis (1967) (75)
Abnormal concentration and anomalous distribution of apolipoprotein A-I in Tangier disease. (1978) (70)
THE EFFECT OF LIGATION OF THE COMMON BILE DUCT ON CHOLESTEROL SYNTHESIS IN THE RAT (1953) (70)
The lipoproteins and lipid transport in abetalipoproteinemia. (1966) (68)
Changes in high-density lipoprotein protein composition after heparin-induced lipolysis. (1971) (65)
Neuropathy in Tangier disease. Alpha-Lipoprotein deficiency manifesting as familial recurrent neuropathy and intestinal lipid storage. (1967) (65)
The differentiation of exogenous and endogenous hyperlipemia by paper electrophoresis. (1965) (64)
The effect of massive cortisone therapy on measurements of thyroid function. (1952) (64)
A further characterization of lipoprotein lipase. (1968) (63)
A new mechanism of exogenous hyperglyceridemia. (1969) (62)
THE METABOLISM 14C-LABELED CIS AND TRANS ISOMERS OF OCTADECENOIC AND OCTADECADIENOIC ACIDS. (1964) (61)
β-Galactosidase in Tissue Culture Derived from Human Skin and Bone Marrow: Enzyme defect in GM1 Gangliosidosis (1969) (61)
The use of polyacrylamide gel electrophoresis in differentiating type 3 hyperlipoproteinemia. (1973) (60)
AMELIORATION OF HYPERTRIGLYCERIDÆMIA BY PROGESTATIONAL DRUGS IN FAMILIAL TYPE-V HYPERLIPOPROTEINÆMIA (1969) (54)
Hyperlipoproteinemia. A review of the five types with first report of necropsy findings in type 3. (1970) (54)
The in vitro production of 25- and 26-hydroxycholesterol and their in vivo metabolism. (1956) (52)
Norethindrone acetate, postheparin lipolytic activity, and plasma triglycerides in familial types I, 3, IV, and V hyperlipoproteinemia. Studies in 26 patients and 5 normal persons. (1971) (51)
Structural and compositional changes attending the ultracentrifugation of very low density lipoproteins. (1975) (51)
The effect of hypothalamic lesions on thyroid function in the dog. (1955) (48)
Properties of the plasma very low and low density lipoproteins in Tangier disease. (1978) (46)
Biomedical research in the 1980s. (1981) (42)
Accumulation of oxygenated steryl esters in Wolman's disease. (1975) (42)
Tangier disease: one explanation of lipid storage. (1978) (41)
The conversion of cholesterol-4-C14 to acids and other products by liver mitochondria. (1956) (41)
Newly Recognized Disorders of Cholesterol Metabolism. (1963) (41)
The Metabolic Basis of Inherited Disease, 2nd ed (1966) (41)
Metabolism of chylomicron proteins in the dog. (1959) (39)
Plasma lipoproteins and apolipoproteins. (1974) (38)
Cardiovascular pathology in hyperlipoproteinemia (HLP) (1973) (38)
The current status of hypolipidemic drugs. (1970) (37)
It's time to be practical. (1975) (37)
Primary hyperlipoproteinemia in infants. (1973) (37)
Correction of COOH-terminal amino acids of human plasma very low density apolipoproteins. (1971) (37)
Isolation and alignment of the tryptic peptides of alanine apolipoprotein, an apolipoprotein from human plasma very low density lipoproteins. (1974) (36)
Positional specificity of triglyceride lipases in post-heparin plasma. (1973) (36)
Landry-Guillain-Barré syndrome. (1959) (35)
Phenotyping On Reaching Base Camp (1950‐1975) (1993) (34)
The Efficacy of Clofibrate (CPIB) in Familial Hyperlipoproteinemias (1969) (34)
Observations on the conformation of human beta lipoprotein: evidence for the occurrence of beta structure. (1968) (33)
Mutants, hyperlipoproteinaemia, and coronary artery disease. (1971) (32)
Beta-sitosterolemia and xanthomatosis. (1976) (31)
Inhibition of Lipid Synthesis by Alpha-Phenyl-N-Butyrate and Related Compounds (1955) (30)
The structure and properties of human beta-lipoprotein and beta-apoprotein. (1968) (29)
The Role of Lipids in Acute Myocardial Infarction (1969) (28)
Cutaneous cholesterol ester deposition in Tangier disease. (1967) (28)
Hydrolysis of diglyceride and glyceryl monoester diethers with "lipoprotein lipase". (1970) (27)
The spleen in type I hyperlipoproteinemia. Histochemical, biochemical, microfluorometric and electron microscopic observations. (1971) (27)
Inhibition of Adrenocortical Steroid Secretion by Δ4-Cholestenone (1958) (27)
"The Recombinant DNA Controversy: A Memoir: Science, Politics, and the Public Interest 1974-1981" [Cover] (2001) (26)
Human serum beta-lipoprotein: preparation and properties of a delipidated, soluble derivative. (1968) (25)
The heart in Tangier disease. Severe coronary atherosclerosis with near absence of high-density lipoprotein cholesterol. (1992) (24)
Familial adult-onset proximal spinal muscular atrophy. Report of a family with type II hyperlipoproteinemia. (1970) (23)
A comparaive study of the effects of chemical modification on the immunochemical and optical properties of human plasma low-density lipoprotein(s) and apoproteins. (1973) (22)
PERSISTENCE OF A METABOLIC DEFECT IN TISSUE CULTURES DERIVED FROM PATIENTS WITH NIEMANN–PICK DISEASE (1967) (22)
The field trial: some thoughts on the indispensable ordeal. (1968) (21)
The Recombinant DNA Controversy (2001) (21)
Failure of Alpha‐Phenylbutyrate and Beta‐Phenylvalerate in Treatment of Hypercholesterolemia (1957) (20)
[Classification of hyperlipidemias and hyperlipoporteinemias. II]. (1972) (20)
Tangier Disease (Familial Cholesterolosis with High-Density Lipoprotein Deficiency) (1962) (19)
Lipid abnormalities in foam cell reticulosis of mice, an analogue of human sphingomyelin lipidosis. (1969) (18)
A physician's guide to hyperlipidemia. (1972) (18)
The Typing of Hyperlipoproteinemia: A Progress Report (1968) (1969) (18)
Studies on the enzymatic degradation of the cholesterol side chain. II. Requirements of the mitochondrial system. (1957) (17)
Chylomicrons and the formation of foam cells in type I hyperlipoproteinemia. A morphologic study. (1973) (16)
Cholesteryl ester storage disease: a most unusual manifestation of deficiency of two lysosomal enzyme activities. (1972) (16)
BIOCHEMICAL STUDIES IN A PATIENT WITH A TANGIER SYNDROME (1978) (16)
Effects of δ4-Cholestenone in Animals and in Man (1958) (16)
The regulation of plasma lipoprotein concentrations as affected in human mutants. (1969) (15)
Some biochemical aspects of lipid and lipoprotein metabolism. (1957) (14)
Health and the search for new knowledge. (1977) (13)
Resting levels of blood fibrinolysis in hyperlipoproteinemia. (1974) (12)
Partial delipidation of human serum β-lipoprotein by sodium decyl sulfate (1969) (11)
Lipid, glucose, and insulin interrelationships in normal, prediabetic, and chemical diabetic subjects. (1976) (10)
Thyroid Uptake of Radioactive Iodine in the Dog; Effect of Diet, Hypophysectomy, and TSH.∗ † (1955) (10)
The Complete Amino Acid Sequence of CI ( ApoLp-Ser ) , an Apolipoprotein from Human Very Low Density Lipoproteins (2003) (9)
THE REMOVAL OF PALMITIC ACIDiC ' LABELED CHYLOMICRA FROM DOG PLASMA (9)
New Drugs in the Treatment of Hyperlipidemia (1968) (9)
Amelioration of hypertriglyceridaemia by progestational drugs in familial type-V hyperlipoproteinaemia. (1969) (9)
Human Serum Beta-Lipoprotein (1968) (9)
Human Serum Beta Lipoprotein and Beta Apoprotein (1969) (7)
"The Recombinant DNA Controversy: A Memoir: Science, Politics, and the Public Interest 1974-1981" [Introductory Material] (2001) (7)
The apolipoproteins. (1972) (7)
The short-term effect of cortisone acetate upon fasting triglyceride and cholesterol in normal subjects and offspring of diabetic couples. (1972) (7)
A History of the Recombinant DNA Guidelines in the United States (1979) (7)
Persistence of a lipid defect in tissue cultures derived from patients with Niemann-Pick disease (1964) (7)
Selective Measurement of Lipoprotein Lipase and Hepatic Lipase in Post-Heparin Plasma (1974) (6)
A Functional View of the Plasma Lipoproteins (1966) (6)
Treatment of essential hyperlipidaemia. (1970) (6)
Biomedical Science and the Culture Warp (1993) (5)
Estimation oftheConcentration of Low-Density Lipoprotein Cholesterol inPlasma, Without UseofthePreparative Ultracentrifuge (1972) (5)
Sorting out the doctor's bag. (1980) (5)
Function and structure of plasma lipoproteins. (1974) (4)
Isolation and characterization of an abnormal high density lipoprotein in Tangier Diesase. (1977) (4)
The National Institutes of Health yesterday, today, and tomorrow. (1978) (3)
Studies of the Protein Defect in Tangier Disease (1970) (3)
Classification and features of the lipidoses affecting the nervous system. (1968) (3)
Plasma lipoproteins: micellar models and mutants. (1969) (3)
The First Twenty-Five Years after Asilomar (2001) (3)
Inhibition of adrenocortical steroid secretion by delta 4-cholestenone. (1958) (3)
Complete genomic sequence of the human ABCA1 gene: analysis of the human (2001) (3)
"Venice' is not sinking (the water is rising). Some views on biomedical research. (1982) (3)
Summary Statement by Donald S. Fredrickson, M.D., Director, National Institutes of Health, on Recombinant DNA Technology before the Subcommittee on Health and Scientific Research of the Senate Committee on Human Resources (1977) (2)
Cardiovascular Pathology in Hyperlipoproteinemia (HLP). (1973) (2)
Tonsils, apolipoproteins and enzymes. (1972) (2)
On the Lipoprotein Abnormality in Type III (2)
Coronary Artery Disease Risk in Familial Type II Hyperlipoproteinemia (1974) (1)
Recombinant DNA Guidelines: Environmental Impact Statement (1976) (1)
The distribution of paralysis in the Landry-Guillain-Barre syndrome. (1962) (1)
The Revising of the Guidelines (2001) (1)
Tonsils and Apolipoproteins: Lessons about Plasma Lipoproteins Derived from Tangier Disease and Other Mutants (1974) (1)
On the cultivation of virtue. (1983) (1)
Preparation and properties of an apoprotein derivative of human serum beta-lipoprotein. (1968) (1)
On cultivating prognosis in cardiovascular research. (1968) (1)
The government role in biomedical research. (1976) (1)
"The case of the yellow palms" and other syndromes in need of detection. (1967) (1)
Is there a federal philosophy about academic medicine. (1981) (1)
The First Heart Transplant in Man (1997) (1)
Federally supported human nutrition research, training, and education. (1981) (1)
Lipolytic Activities of Hepatic Plasma Membrane Origin in Postheparin Plasma (1974) (1)
10th Anniversary Colloquium. Medicine, public health, and environment. (1994) (1)
Report of the National Heart and Lung Institute Panel on Hyperlipidemia and Premature Atherosclerosis (1970) (1)
[Excerpt from Donald S. Fredrickson's diary on the exemption of E. coli experiments from the NIH Guidelines for Research Involving Recombinant DNA Molecules] (1979) (1)
The Arabian Nights (1990) (1)
Factors in childhood that influence the development of atherosclerosis and hypertension: introduction. (1972) (1)
[Donald Fredrickson's speech to the Academy of the Kingdom of Morocco] (1982) (1)
On thelipoprotein abnormality in type 3 hyperlipoproteinemia. (1971) (1)
The public governance of science. (1978) (1)
Introduction: The Anfinsen Series (1984) (0)
Inhibition of Adrenocortical Steroid Secretion by Δ 4 -Cholestenone (1958) (0)
Norethindrone Acetate, Postheparin Lipolytic Activity, and Plasma Triglycerides in Familial Types I, III, IV, and V Hyperlipoproteinemia (2020) (0)
Selected Papers on Lipoproteins and Atherosclerosis (1970) (0)
Letter from Donald S. Fredrickson to Daniel E. Koshland, Jr (1976) (0)
NIH tackles cost accounting issues. (1981) (0)
[Recording of Dr. Fredrickson reading "The Moral"] (Audio cassette) (1997) (0)
Research fellowships. (1976) (0)
"Freedom from Want" (Donald Fredrickson's high school valedictorian address) (1942) (0)
[Excerpt from Fredrickson's diary on the release of the recombinant DNA guidelines into the Federal Register] (1978) (0)
Figurative illustration of a lipoprotein (1954) (0)
Handbooks on the Dietary Management of Hyperlipoproteinemia (covers) (1964) (0)
"Lipoprotein Patterns and Atherosclerosis" [color] (1966) (0)
Personal reminiscence on being President of the Institute of Medicine (1997) (0)
The Environmental Impact Statement and the Polyoma Experiment 1976–77 (2001) (0)
I.O.M. [Institute of Medicine]: Memoires a l'Accouchement (1990) (0)
Welcoming remarks (1979) (0)
A conversation with Donald Sharp Fredrickson, MD, Director of the National Institutes of Health: an exclusive journal profile/interview. Interview by Blaine Taylor. (1979) (0)
Treatment of hypercholesteremia and hypertriglyceridemia. (1969) (0)
PRIMARY HYPERLIPOPROTEINE MIA IN INFANTS 7082 (1973) (0)
[Fredrickson reading an excerpt from "A History of Recombinant DNA Guidelines in the United States"] (1997) (0)
Preparation and properties of an apoprotein derivative of human serum β-lipoprotein (1968) (0)
Partial delipidation of human serum beta-lipoprotein by sodium decyl sulfate. (1969) (0)
Asilomar: the End of the Beginning † (2001) (0)
Lipoprotein Patterns and Atherosclerosis (1966) (0)
Plasma Lipoproteins: Disorders in Their Metabolism. (1971) (0)
"Lipoprotein Patterns and Atherosclerosis" [page eight, color] (1966) (0)
[Personal reminiscence of President Lyndon B. Johnson's 1967 visit to NIH] (1965) (0)
Returning to the Witness Table: the Remainder of the 95th Congress 1977–78 (2001) (0)
The visible internists. (1976) (0)
Human experimentation. (1975) (0)
Letter from Donald S. Fredrickson to Richard S. Schweiker, Department of Health and Human Services (1981) (0)
Introductory Notes on a Bibliography (1978) (0)
The Plasma Lipoproteins (Episodic View) (1993) (0)
"Opening Remarks" at a symposium in memory of Gordon Tomkins (1976) (0)
A correspondence between Fredrick J. Stare and Donald S. Fredrickson on diet and coronary heart disease (1972) (0)
"Seeking Technical Consensus on Medical Intervention" [Editorial] (1978) (0)
Letter from Donald S. Fredrickson to Patricia Harris, Department of Health and Human Services (1980) (0)
"Lipoprotein Patterns and Atherosclerosis" [title page, color] (1966) (0)
[Excerpt from Fredrickson's diary on the reaction of several scientists to restructuring the Recombinant DNA Research Advisory Committee] (1979) (0)
Interview with NIH Director Donald Fredrickson on NIH as research (1978) (0)
Letter from Donald S. Fredrickson to C. Arthur Fredrickson, Blanche Fredrickson (1943) (0)
Interagency Meeting on Federal Research Into the Biological Effects of Ionizing Radiation (1979) (0)
A Federal Case (2001) (0)
[Excerpt from Fredrickson's diary on the subsequent revisions of the recombinant DNA guidelines] (1988) (0)
An overview statement on the National Conference on Health Research Principles. (1979) (0)
Cholestyramine in Type II Hyperlipoproteinemia (2020) (0)
"A Fading King's Bequest" [Fredrickson's departing poem to NIH] (1981) (0)
In Defense of Washington (1986) (0)
Snippets of science (1982) (0)
Book Reviews (1966) (0)
The Gathering Storm 1975 (2001) (0)
Description of the photograph of the conference on cardiac transplantation with Christiaan Barnard (1967) (0)
Acts of Congress 1977 (2001) (0)
Communal resources, community responsibilities. (1981) (0)
The Debt to Taft (1989) (0)
Treatment of hypertriglyceridaemia. (1969) (0)
[Behavior of the lipid pattern and electrophoretic lipid levels in children with hepatitis A]. (1976) (0)
Serendipity—Code word for planning (1967) (0)
Recombinant DNA guidelines: environmental impact statement. (1976) (0)
Hyperlipoproteinemia Summary Table (1970) (0)
THE METABOLISM OF SPHINGOMYELIN, H. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN NIEMANN-PICK DISEASE (2003) (0)
National Conference on Clinical Trials Methodology: welcoming remarks. (1979) (0)
Winding Down 1979–81 (2001) (0)
Interview with NIH Director Donald Fredrickson on costs and technology (1978) (0)
NIH placed accent on health research. (1979) (0)
[Cells in Nieman-Pick disease and various other lopoidoses]. (1963) (0)
Letter from Donald S. Fredrickson to C. Arthur and Blanche Fredrickson (1948) (0)
Descriptive notes by Donald Fredrickson on the contents of his childhood scrapbook (1990) (0)
STASFO~D U~IVEKSITY MEDICAL CENTER (2002) (0)
Purification and Properties of Two Sphingolipid Hydrolases (1972) (0)
"Two Challenges to Negative Prophecy: 'Clinical Applications Units' and 'The Cloister Project'" [HHMI President's Report to Trustees] (1984) (0)
Interview with NIH Director Donald Fredrickson on the nature of discovery (1978) (0)
Partnership of Federal agencies and the cardiologist in research, teaching and practice. (1967) (0)
The Rights of Man and the World Wide Web (1996) (0)
A Major Action 1978–79 (2001) (0)
[Resignation] Letter from Donald S. Fredrickson to President Ronald Reagan (1981) (0)
[Excerpts from Donald Fredrickson's inaugural speech as President of the Institute of Medicine] (1974) (0)
An Overview of the Role of NIH and Other Federal Agencies in the Conduct of Research with Recombinant DNA (1977) (0)
Challenge of change in biology (1987) (0)
Letter from Donald S. Fredrickson to Evelyn Attix, National Institutes of Health (1982) (0)
[Excerpt from Fredrickson's diary on a hearing with Adlai Stevenson III] (1977) (0)
Recombinant Ramblings 1976–77 (2001) (0)
The search for the Omphalos. (1976) (0)
Remarks to the NIH Community (1981) (0)
A SCIENTIST'S VIEW OF PRIORITIES AND CONTROL IN THE ORGANIZATION OF RESEARCH (1979) (0)
Aesculapian merry-go-round. (1977) (0)
Who Shall Eat All the Eggs (1970) (0)
Extending the Seed of Power to the Public 1976 (2001) (0)
Some publications by Donald S. Fredrickson on research related to plasma lipids and lipoproteins (annotated by author) (1997) (0)
[Excerpt from Fredrickson's diary on the tension between himself and Department of Health and Human Services Secretary Patricia Harris] (1980) (0)
Current attitudes about atherosclerosis. (1958) (0)
[Excerpt from Fredrickson's diary on his impending departure from NIH] (1981) (0)
Research findings of potential value to the practitioner. (1979) (0)
Interview with NIH Director Donald Fredrickson on the future of research (1978) (0)
Letter from Donald S. Fredrickson to Joshua Lederberg (1977) (0)
NIH: a century of science for health. Challenge of change in biology. (1987) (0)
The developmental history of the clinician. (1951) (0)
Depiction of the state of knowledge about abnormalities in lipid metabolism around 1950 (1970) (0)
OBSERVATIONS ON THE CONFORMATION OF HUMAN BET'A LIPOPROTEIN: EVIDENCE FOR THE OCCURRENCE OF BETA STRUCTURE BY A. MI. GoTTo, (0)

This paper list is powered by the following services:

Donald S. Fredrickson's Academic­Influence.com Rankings

Donald S. Fredrickson's Degrees

Why Is Donald S. Fredrickson Influential?

Donald S. Fredrickson's Published Works

Published Works

Donald S. Fredrickson's AcademicInfluence.com Rankings